| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.36 | 4e-25 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.28 | 7e-15 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.23 | 8e-12 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-10 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.21 | 9e-10 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.19 | 5e-09 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.29 | 5e-09 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-09 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-08 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-07 |